As the discontinuation of sales of 31 items of Metformin used as a treatment for type II diabetes patients is decided, the shortage of alternative products is intensifying.

The MFDS announced that it will temporarily manufacture, sell, and discontinue prescriptions for 31 items containing Metformin, which are used as a primary treatment for type II diabetes patients today (26).

Along with the announcement of the MFDS, a notice was sent to the pharmacists of Korean Pharmaceutical Association, and pharmacists had a busy time checking the related items and organizing their inventory immediately after work.

Pharmacists need to order replacement items immediately if the product the